Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Cash spent on acquiring or upgrading physical assets
Latest
$-33.84M
↓ 85% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-18.26M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-33.84M | -205.7% |
| 2024 | $-11.07M | +50.3% |
| 2023 | $-22.29M | -9.1% |
| 2022 | $-20.43M | +45.6% |
| 2021 | $-37.57M | +19.7% |
| 2020 | $-46.79M | -576.5% |
| 2019 | $-6.92M | -477.4% |
| 2018 | $-1.20M | -16.5% |
| 2017 | $-1.03M | +32.4% |
| 2016 | $-1.52M | - |